Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ABEO
#3370
Abeona Therapeutics Inc. Common Stock
5.2
6
USD
+1.35%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+1.35%
Aylık Değişim
+10.50%
6 aylık değişim
-5.23%
Yıllık Değişim
+8.45%
Önceki Kapanış
5.1
9
Open
5.2
1
Bid
Ask
Low
5.2
1
High
5.2
7
Hacim
86
Piyasalar
ABD Borsası
Sağlık Hizmetleri
ABEO
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
48.53 M
51.16 M
51.28 M
54.19 M
57.05 M
—
Valuation ratios
Enterprise value
265.94 M
246.86 M
147.29 M
223 M
242.25 M
859.39 M
Price to earnings ratio
-3.59
-7.56
4.24
2.82
5.22
4.72
Price to sales ratio
—
—
946.3
879.66
59.89
—
Price to cash flow ratio
-4.08
-3.73
-4.34
-3.65
-4.57
-16.29
Price to book ratio
5.19
1.11
1.07
0.7
2.19
5.07
Enterprise value to EBITDA ratio
-4.25
-3.6
-2.02
-2.7
-2.7
-11.02
Profitability ratios
Return on assets %
-0.09
-0.12
0.44
-0.02
-0.09
0.21
Return on equity %
-0.21
-0.29
0.67
-0.03
-0.13
0.22
Return on invested capital %
-401.14
-448.19
-285.1
-81.2
-347.42
-1 161.91
Gross margin %
—
—
100
—
80.74
—
Operating margin %
—
—
-5 698
—
-422.71
—
EBITDA margin %
—
—
-5 562
—
-406.79
—
Net margin %
—
—
27.21 K
—
-377.49
—
Liquidity ratios
Quick ratio
—
—
6.65
9.53
6.74
—
Current ratio
6.08
4.9
6.73
9.74
6.93
28.3
Inventory turnover
—
—
0
0.13
0.2
—
Asset turnover
0
0
0
0
0.02
0.03
Solvency ratios
Debt to assets ratio
0.17
0.19
0.08
0.09
0.09
0.45
Debt to equity ratio
0.43
0.47
0.12
0.12
0.13
0.83
Long term debt to total assets ratio
0.12
0.11
0.06
0.05
0.04
0.25
Long term debt to total equity ratio
0.3
0.27
0.09
0.06
0.05
0.47
Per share metrics
Operating cash flow per share
-0.4
-0.37
-0.28
-0.39
-0.27
-1.31
EBIT per share
-0.41
-0.4
-0.34
-0.44
-0.35
-1.53
EBITDA per share
-0.39
-0.39
-0.33
-0.43
-0.33
-1.48
Total debt per share
0.46
0.39
0.29
0.36
0.3
1.35
Cash per share
2.39
1.7
3.38
3.82
2.89
11.79
Net current asset value per share
2.46
1.77
3.49
3.98
3.1
12.34
Tangible book value per share
1.07
0.83
2.45
3.16
2.41
8.85
Working capital per share
2.05
1.41
2.97
3.58
2.65
10.6
Book value per share
1.07
0.83
2.45
3.16
2.41
8.85
Haberler
Abeona Therapeutics yönetim kuruluna Keith Goldan’ı atadı
Abeona Therapeutics CEO’su 131 bin dolarlık hisse sattı
Abeona Therapeutics: Early Zevaskyn Revenue Marks A Key Inflection Point (NASDAQ:ABEO)
Oppenheimer, Abeona Therapeutics için Outperform notunu korudu
Stifel, Abeona Therapeutics’in hisse hedefini düşürdü
Abeona Therapeutics CFO’su Vazzano 3.700 dolarlık hisse sattı
Abeona Therapeutics CFO Vazzano sells $3.7k in stock
Oppenheimer, Abeona Therapeutics için hedef fiyatı yükseltti
Oppenheimer raises Abeona Therapeutics price target on launch progress
Abeona, ZEVASKYN gen terapisi lansmanında ilerleme kaydetti
Abeona reports progress in ZEVASKYN gene therapy launch
3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts - TipRanks.com